Latest Financial Results
Q3 2020
Quarter Ended Dec 31, 2019
Stock Information
Company Overview
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The company's products, which are sold throughout the world, have improved outcomes for more than ten million patients globally by reducing infection, itch, pain, scarring and harmful inflammatory responses. Sonoma’s headquarters are in Petaluma, California, with manufacturing operations in both the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Investor Contact Information
Company
Sonoma Pharmaceuticals, Inc.
1129 North McDowell Blvd.
Petaluma, CA 94954
Investor Relations
T: 707-559-7380
ir@sonomapharma.com
Transfer Agent
Computershare
462 South 4th Street
Suite 1600
Louisville, KY 40202
T: 888-647-8901